Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1459–544.

Article  Google Scholar 

•• Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. This study forms the prime resource which outlines the global magnitude of total CVD burden (incidence, prevalence, case fatality, mortality, health risks), identifies underlying causes of CVD death, and links them to relevant risk factors.

Article  PubMed  PubMed Central  Google Scholar 

The top 10 causes of death [Internet]. World Health Organization; 2020 Dec 9 [cited 2023 Sep 1]. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

Murray CJL, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–57.

Article  CAS  PubMed  Google Scholar 

Birger M, Kaldjian AS, Roth GA, Moran AE, Dieleman JL, Bellows BK. Spending on cardiovascular disease and cardiovascular risk factors in the United States: 1996 to 2016. Circulation. 2021;144(4):271–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93-621.

Article  PubMed  Google Scholar 

Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff Proj Hope. 2007;26(1):13–24.

Article  Google Scholar 

Huffman MD, Baldridge A, Bloomfield GS, Colantonio LD, Prabhakaran P, Ajay VS, et al. Global cardiovascular research output, citations, and collaborations: a time-trend, bibliometric analysis (1999–2008). PLoS ONE. 2013;8(12):e83440.

Article  PubMed  PubMed Central  Google Scholar 

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet Lond Engl. 2004;364(9438):937–52.

Article  Google Scholar 

O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet Lond Engl. 2016;388(10046):761–75.

Article  Google Scholar 

Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet Lond Engl. 2011;378(9798):1231–43.

Article  Google Scholar 

Joseph P, Kutty VR, Mohan V, Kumar R, Mony P, Vijayakumar K, et al. Cardiovascular disease, mortality, and their associations with modifiable risk factors in a multi-national South Asia cohort: a PURE substudy. Eur Heart J. 2022;43(30):2831–40.

Article  PubMed  Google Scholar 

Classifying countries by income [Internet]. The World Bank; 2019 Sep 9 [cited 2023 Sep 24]. Available from: https://datatopics.worldbank.org/world-development-indicators/stories/the-classification-of-countries-by-income.html.

World Bank Country and Lending Groups [Internet]. World Bank Data Help Desk [cited 2023 Sep 24]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.

Liu J, Bu X, Wei L, Wang X, Lai L, Dong C, et al. Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019. J Hypertens. 2021;39(12):2488–96.

Article  CAS  PubMed  Google Scholar 

Sun J, Qiao Y, Zhao M, Magnussen CG, Xi B. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15–39 years in 204 countries/territories, 1990–2019: a systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023;21(1):222.

Article  PubMed  PubMed Central  Google Scholar 

Wu S, Xu W, Guan C, Lv M, Jiang S, Jinhua Z. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990–2019: an analysis of observational data from a 2019 Global Burden of Disease study. BMJ Open. 2023;13(5):e069397.

Article  PubMed  PubMed Central  Google Scholar 

Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–71.

Article  PubMed  Google Scholar 

Dong C, Bu X, Liu J, Wei L, Ma A, Wang T. Cardiovascular disease burden attributable to dietary risk factors from 1990 to 2019: a systematic analysis of the Global Burden of Disease study. Nutr Metab Cardiovasc Dis NMCD. 2022;32(4):897–907.

Article  PubMed  Google Scholar 

Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease and mortality in 155,722 individuals from 21 high-, middle-, and low-income countries. Lancet Lond Engl. 2020;395(10226):795–808.

Article  Google Scholar 

• Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, et al. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. N Engl J Med. 2014;371(9):818–27. Findings from this study reveal significant metrics to compare CVD risk and events between LICs and HICs, suggesting a substantially highest risk of major CVD and death in LICs. The results highlight the disparity between these regions and identify a lack of implementation of evidence-based practice in LICs.

Article  CAS  PubMed  Google Scholar 

Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, et al. Life’s Essential 8: updating and enhancing the American Heart Association’s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18-43.

Article  PubMed  PubMed Central  Google Scholar 

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-646.

PubMed  PubMed Central  Google Scholar 

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.

Article  PubMed  Google Scholar 

Teo KK, Rafiq T. Cardiovascular risk factors and prevention: a perspective from developing countries. Can J Cardiol. 2021;37(5):733–43.

Article  PubMed  Google Scholar 

Franco M, Cooper RS, Bilal U, Fuster V. Challenges and opportunities for cardiovascular disease prevention. Am J Med. 2011;124(2):95–102.

Article  PubMed  Google Scholar 

•• Qureshi NQ, Mufarrih SH, Bloomfield GS, Tariq W, Almas A, Mokdad AH, et al. Disparities in cardiovascular research output and disease outcomes among high-, middle- and low-income countries — an analysis of global cardiovascular publications over the last decade (2008–2017). Glob Heart. 2021;16(1):4. This study outlines global cardiovascular publications over the last decade according to country development indicators. The results reveal a distinct disparity in research output and CVD burden between LICs and HICs and identify an urgent need to strengthen research capacity within LICs to bridge this gap.

Article  PubMed  PubMed Central  Google Scholar 

Myers L, Mendis S. Cardiovascular disease research output in WHO priority areas between 2002 and 2011. J Epidemiol Glob Health. 2013;4(1):23–8.

Article  PubMed  PubMed Central  Google Scholar 

Abushouk AI, Sayed A, Ghanem E, Hassanin A, Mentias A, Bendary A, et al. Africa on the global stage: analyzing 30 years of African-led clinical trials in cardiovascular medicine. Circ Cardiovasc Qual Outcomes. 2023;16(9):e009895.

Article  PubMed  Google Scholar 

Mendis S, Yach D, Bengoa R, Narvaez D, Zhang X. Research gap in cardiovascular disease in developing countries. Lancet. 2003;361(9376):2246–7.

Article  CAS  PubMed  Google Scholar 

Drubin DG, Kellogg DR. English as the universal language of science: opportunities and challenges. Mol Biol Cell. 2012;23(8):1399.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pascual-Leone N, Liu JW, Beschloss A, Chenna SS, Saifi C. The language of all medical publications and spine publications from 1950 to 2020. North Am Spine Soc J. 2022;21(10):100118.

Google Scholar 

Amano T, González-Varo JP, Sutherland WJ. Languages are still a major barrier to global science. PLOS Biol. 2016;14(12):e2000933.

Article  PubMed  PubMed Central  Google Scholar 

Ransing R, Vadivel R, Halabi SE, Jatchavala C, Shalbafan M, Noël C, et al. Language as multi-level barrier in health research and the way forward. Indian J Psychol Med. 2023;45(1):65–8.

Article  PubMed  Google Scholar 

Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther. 1999;13(2):95–104.

Article  CAS  PubMed  Google Scholar 

Many Low- or Middle-Income Countries unprepared for the battle against cardiovascular disease [Internet]. University of Birmingham; 2023 Sep 22 [cited 2023 Sep 24]. Available from: https://www.birmingham.ac.uk/news/2023/many-low-or-middle-income-countries-unprepared-for-the-battle-against-cardiovascular-disease.

The 17 Goals - Sustainable Development [Internet]. United Nations [cited 2023 Aug 25]. Available from: https://sdgs.un.org/goals.

Alemayehu C, Mitchell G, Nikles J. Barriers for conducting clinical trials in developing countries — a systematic review. Int J Equity Health. 2018;17(1):37.

Article  PubMed  PubMed Central  Google Scholar 

Nicholls M. The PURE study implications. Eur Heart J. 2018;39(48):4227–9.

Article  PubMed  Google Scholar 

Pena MSB, Bloomfield GS. Cardiovascular disease research and the development agenda in low- and middle-income countries. Glob Heart. 2015;10(1):71–3.

Article  Google Scholar 

Public consultation on WHO guidance for best practices for clinical trials [Internet]. World Health Organization; 2023 Jul 19 [cited 2023 Sep 23]. Available from: https://www.who.int/news-room/articles-detail/public-consultation-on-who-guidance-for-best-practices-for-clinical-trials.

Social determinants of health [Internet]. World Health Organization [cited 2023 Sep 1]. Available from: https://www.who.int/health-topics/social-determinants-of-health.

Islam MM. Social determinants of health and related inequalities: confusion and implications. Front Public Health. 2019;8(7):11.